{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:42:52Z","timestamp":1785577372872,"version":"3.56.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010846","name":"Health and Family Planning Commission of Hubei Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010846","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010846","name":"Health and Family Planning Commission of Hubei Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010846","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.lfs.2019.117010","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T12:14:09Z","timestamp":1572264849000},"page":"117010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Amlexanox reversed non-alcoholic fatty liver disease through IKK\u03b5 inhibition of hepatic stellate cell"],"prefix":"10.1016","volume":"239","author":[{"given":"Qian","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kecheng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renmin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiulan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2019.117010_bib1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41575-019-0144-8","article-title":"Past, present and future perspectives in nonalcoholic fatty liver disease","volume":"16","author":"Sanyal","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2019.117010_bib2","doi-asserted-by":"crossref","first-page":"32345","DOI":"10.1074\/jbc.M313478200","article-title":"Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease","volume":"279","author":"Samuel","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2019.117010_bib3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nm1185","article-title":"IKK-beta links inflammation to obesity-induced insulin resistance","volume":"11","author":"Arkan","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2019.117010_bib4","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI25102","article-title":"Inflammation, stress, and diabetes","volume":"115","author":"Wellen","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.lfs.2019.117010_bib5","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1126\/science.1061620","article-title":"Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta","volume":"293","author":"Yuan","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.lfs.2019.117010_bib6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/ard.2008.095356","article-title":"Synergistic benefit in inflammatory arthritis by targeting I kappaB kinase epsilon and interferon beta","volume":"68","author":"Corr","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.lfs.2019.117010_bib7","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ni.2080","article-title":"The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation","volume":"12","author":"Bulek","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2019.117010_bib8","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cell.2009.06.046","article-title":"The protein kinase IKKepsilon regulates energy balance in obese mice","volume":"138","author":"Chiang","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2019.117010_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000233861","article-title":"Mechanism of the action of amoxanox (AA-673), an orally active antiallergic agent","volume":"78","author":"Saijo","year":"1985","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"key":"10.1016\/j.lfs.2019.117010_bib10","first-page":"5","article-title":"Clinical study to know the efficacy of Amlexanox 5% with other topical Antiseptic, Analgesic and Anesthetic agents in treating minor RAS","volume":"6","author":"Darshan","year":"2014","journal-title":"J. Int. Oral Health"},{"key":"10.1016\/j.lfs.2019.117010_bib11","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2174\/1745017901814010700","article-title":"A randomized, double-blind, placebo-controlled trial on clinical efficacy of topical agents in reducing pain and frequency of recurrent aphthous ulcers","volume":"12","author":"Sharma","year":"2018","journal-title":"Open Dent. J."},{"key":"10.1016\/j.lfs.2019.117010_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.3082","article-title":"An inhibitor of the protein kinases TBK1 and IKK-varepsilon improves obesity-related metabolic dysfunctions in mice","volume":"19","author":"Reilly","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2019.117010_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.lfs.2019.117010_bib14","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.27332","article-title":"Hepatic inflammation and fibrosis: functional links and key pathways","volume":"61","author":"Seki","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2019.117010_bib15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2019.117010_bib16","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1111\/bph.12955","article-title":"Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP","volume":"172","author":"McGrath","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2019.117010_bib17","doi-asserted-by":"crossref","first-page":"12082","DOI":"10.3748\/wjg.v20.i34.12082","article-title":"Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic","volume":"20","author":"Hassan","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2019.117010_bib18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/labinvest.2014.11","article-title":"Metabolically induced liver inflammation leads to NASH and differs from LPS- or IL-1beta-induced chronic inflammation","volume":"94","author":"Liang","year":"2014","journal-title":"Lab. Investig."},{"key":"10.1016\/j.lfs.2019.117010_bib19","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2019.117010_bib20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bbrc.2011.02.137","article-title":"Beneficial effects of IKKepsilon-deficiency on body weight and insulin sensitivity are lost in high fat diet-induced obesity in mice","volume":"407","author":"Scheja","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2019.117010_bib21","article-title":"Amlexanox suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2019.117010_bib22","first-page":"169","article-title":"Silencing of IKKepsilon using siRNA inhibits proliferation and invasion of glioma cells in vitro and in vivo","volume":"41","author":"Li","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lfs.2019.117010_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33875-0","article-title":"Inhibition of TBK1\/IKKepsilon promotes regeneration of pancreatic beta-cells","volume":"8","author":"Xu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2019.117010_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1073\/pnas.2237236100","article-title":"IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts","volume":"101","author":"McWhirter","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.lfs.2019.117010_bib25","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1158\/2159-8290.CD-16-0955","article-title":"Biomarker accessible and chemically addressable mechanistic subtypes of BRAF melanoma","volume":"7","author":"Eskiocak","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.lfs.2019.117010_bib26","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1158\/0008-5472.CAN-17-0829","article-title":"TBK1 provides context-selective support of the activated AKT\/mTOR pathway in lung cancer","volume":"77","author":"Cooper","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2019.117010_bib27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.leukres.2016.04.012","article-title":"Identification of TBK1 and IKKepsilon, the non-canonical IkappaB kinases, as crucial pro-survival factors in HTLV-1-transformed T lymphocytes","volume":"46","author":"Zhang","year":"2016","journal-title":"Leuk. Res."},{"key":"10.1016\/j.lfs.2019.117010_bib28","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1073\/pnas.1316255111","article-title":"Elevated expression of TANK-binding kinase 1 enhances tamoxifen resistance in breast cancer","volume":"111","author":"Wei","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.lfs.2019.117010_bib29","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/intimm\/11.8.1357","article-title":"IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases","volume":"11","author":"Shimada","year":"1999","journal-title":"Int. Immunol."},{"key":"10.1016\/j.lfs.2019.117010_bib30","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/35008109","article-title":"NAK is an IkappaB kinase-activating kinase","volume":"404","author":"Tojima","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2019.117010_bib31","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/cells8020178","article-title":"Essential roles for the non-canonical IkappaB kinases in linking inflammation to cancer, obesity, and diabetes","volume":"8","author":"Shin","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2019.117010_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.396","article-title":"Amlexanox, a selective inhibitor of IKBKE, generates anti-tumoral effects by disrupting the Hippo pathway in human glioblastoma cell lines","volume":"8","author":"Liu","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2019.117010_bib33","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2165\/00044011-200525090-00001","article-title":"Amlexanox for the treatment of recurrent aphthous ulcers","volume":"25","author":"Bell","year":"2005","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.lfs.2019.117010_bib34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000234292","article-title":"Mechanism of action of an antiallergic agent, amlexanox (AA-673), in inhibiting histamine release from mast cells. Acceleration of cAMP generation and inhibition of phosphodiesterase","volume":"82","author":"Makino","year":"1987","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"key":"10.1016\/j.lfs.2019.117010_bib35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cmet.2017.06.006","article-title":"Inhibition of IKKvarepsilon and TBK1 improves glucose control in a subset of patients with type 2 diabetes","volume":"26","author":"Oral","year":"2017","journal-title":"Cell Metabol."},{"key":"10.1016\/j.lfs.2019.117010_bib36","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1073\/pnas.1016132108","article-title":"IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation","volume":"108","author":"Xie","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.lfs.2019.117010_bib37","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1038\/ncomms7047","article-title":"A subcutaneous adipose tissue-liver signalling axis controls hepatic gluconeogenesis","volume":"6","author":"Reilly","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2019.117010_bib38","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.bbadis.2015.05.015","article-title":"Recent insights on the role of cholesterol in non-alcoholic fatty liver disease","volume":"1852","author":"Arguello","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2019.117010_bib39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2012.02.028","article-title":"Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis","volume":"57","author":"Leroux","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2019.117010_bib40","doi-asserted-by":"crossref","first-page":"7499","DOI":"10.1038\/s41598-018-25699-9","article-title":"Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis","volume":"8","author":"Kim","year":"2018","journal-title":"Sci. Rep."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519309373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519309373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:28:51Z","timestamp":1758400131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320519309373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":40,"alternative-id":["S0024320519309373"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.117010","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amlexanox reversed non-alcoholic fatty liver disease through IKK\u03b5 inhibition of hepatic stellate cell","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.117010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117010"}}